Thermo Fisher Scientific Inc (TMO)-Medical Equipment-Deals and Alliances Profile

Thermo Fisher Scientific Inc (TMO)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME1017D
  • |
  • Pages: 249
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It also delivers a broad selection of analytical instruments, equipment, consumables and laboratory supplies. The company serves pharmaceutical and biotech companies, universities, hospitals and clinical diagnostic labs, research institutions and government agencies; and environmental, industrial quality and process control sectors. It also offers various specialty brands that cover a range of consumable products for the life and laboratory sciences industry. It sells its products and services through direct sales force, customer-service professionals, electronic commerce and third-party distributors in the Americas, Asia-Pacific and Europe. Thermo Fisher is headquartered in Massachusetts, the US.

Thermo Fisher Scientific Inc (TMO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 8

List of Figures 12

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 13

Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 15

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 16

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 17

Thermo Fisher Scientific Inc, Medical Equipment, Deal Details 26

Asset Purchase 26

Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For US$15 Million 26

Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics 27

Venture Financing 27

KonTEM Raises Funds Through Venture Financing 27

Private Equity 28

GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 28

Partnerships 29

One Lambda Enters into Licensing Agreement with Transcriptome Sciences 29

Singulex Enters into Licensing agreement with Thermo Fisher Scientific 30

Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology 31

Affymetrix Enters into Licensing Agreement with Peptide Groove 31

diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 32

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 33

Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test 34

Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 35

Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay 35

Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 36

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 37

Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 38

Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 39

Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology 39

Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries 40

Affymetrix Enters Into Licensing Agreement With Genisphere 41

Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 42

Seegene Enters into Agreement with Thermo Fisher Scientific 43

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 44

Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital 44

Asuragen Enters into Agreement with Thermo Fisher Scientific 45

Invivoscribe Enters into Agreement with Thermo Fisher Scientific 46

Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific 47

Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 47

Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed 48

Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 49

Strata Oncology Enters into Agreement with Thermo Fisher Scientific 50

Thermo Fisher Scientific Partners with University of Birmingham 50

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 51

Thermo Fisher Scientific Enters into Co-Development Agreement with Children's Hospital Los Angeles 52

Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific 53

Affymetrix Enters into Agreement with Reveal Biosciences 54

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 54

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 55

XRGenomics Enters into Research Agreement with Affymetrix 56

Affymetrix Enters into Distribution Agreement with Luminex 57

Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 57

Cytox Enters into Joint Development Partnership with Affymetrix 58

Atossa Genetics Enters into Distribution Agreement with Thermo Fisher 59

Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 60

Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 60

Ingen Expands Distribution Agreement with One Lambda 61

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 62

Lucigen Enters into Agreement with Thermo Fisher Scientific 63

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 64

Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University 64

Affymetrix Enters Into Integration Agreement With CollabRx 65

Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 66

OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 67

Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 68

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 69

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 70

Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing 71

Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform 71

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 72

Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment 72

Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices 73

Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 74

Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 75

Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 76

Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 77

Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test 78

Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 79

BioDesign Institute Enters Into Co-Development Agreement With Life Technologies 79

Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 80

Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics 81

Biocept Enters into Partnership with Life Technologies 82

Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 82

Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions 83

CollabRx Enters Into Co-Development Agreement With Life Technologies 84

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 85

Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 86

Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 87

Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 87

Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance 88

Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 89

One Lambda Enters Into Co-Marketing Agreement With CellTrend 90

Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 90

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 91

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 92

Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 93

Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 94

Iris International Enters Into Distribution Agreement With Fisher HealthCare 95

IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare 95

Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs 96

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 97

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 98

Life Technologies Enters Into Joint Venture Agreement With DaAn Gene 99

InGen BioSciences Enters into Distribution Agreement with One Lambda 99

Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 100

Sage Science Enters Into Co-Marketing Agreement With Life Technologies 101

Life Technologies Enters Into Co-Marketing Agreement With Quidel 101

Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 102

Luminex Enters Into Distribution Agreement With Life Technologies 103

Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 103

Rapid Micro Biosystems Enters Into Co-Marketing Agreement With Life Technologies 104

Affymetrix Enters Into Distribution Agreement With Thermo Fisher 105

Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 106

Life Technologies Enters Into Licensing Agreement With Novartis 106

Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 107

Equity Offering 108

Affymetrix to Raise USD50 Million in Private Placement of Shares 108

Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million 109

Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion 110

Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 111

Debt Offering 112

Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 112

Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 114

Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 115

Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 117

Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 119

Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 120

Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 121

Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 122

Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 124

Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 125

Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 127

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million 128

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion 130

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million 131

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million 133

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million 135

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million 136

Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 138

Thermo Fisher Scientific Completes Public Offering Of 2.250% Senior Notes Due 2016 For US$1,000 Million 139

Thermo Fisher Scientific Completes Public Offering Of 3.600% Senior Notes Due 2021 For US$1,100 Million 140

Thermo Fisher Scientific Announces Public Offering Of Senior Notes Due 2022 142

Thermo Fisher Scientific Completes Public Offering Of 4.500% Senior Notes Due 2021 For US$1,000 Million 143

Thermo Fisher Scientific Completes Public Offering Of 2.050% Senior Notes Due 2014 For US$300 Million 144

Thermo Fisher Scientific Completes Public Offering Of 3.200% Senior Notes Due 2016 For US$900 Million 145

Acquisition 146

Thermo Fisher Scientific Acquires Finesse Solutions 146

Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 147

Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 149

Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 149

Thermo Fisher Scientific Acquires INEL 151

Thermo Fisher Scientific Acquires Advanced Scientifics for USD300 Million 152

FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM 153

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 153

Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion 154

FEI Company To Acquire nanoTechnology Systems 157

Life Technologies Acquires KDR Biotech, Distributor Of Reagents 158

Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer 158

Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes 159

Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For US$925 Million 160

FEI Acquires Visualization Sciences, 3D Visualization Software Company, For US$55 Million 161

Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 162

Life Technologies Acquires Navigenics 163

Affymetrix Completes Acquisition Of eBioscience For US$315 Million 164

Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience 166

FEI Company Acquires TILL Photonics For US$19.9 Million 166

Thermo Fisher Scientific Acquires Intrinsic Bioprobes 167

Thermo Fisher Completes Acquisition Of Phadia 168

Thermo Fisher Scientific Acquires TREK Diagnostic Systems 169

Thermo Fisher Scientific Acquires Sterilin 170

Thermo Fisher Scientific Completes The Acquisition Of Dionex 171

Quest Diagnostics Completes Acquisition Of Athena Diagnostics 173

Thermo Fisher Scientific Inc - Key Competitors 176

Key Employees 177

Locations And Subsidiaries 179

Head Office 179

Other Locations & Subsidiaries 179

Recent Developments 184

Financial Announcements 184

Apr 26, 2017: Thermo Fisher Scientific Reports First Quarter 2017 Results 184

Jan 31, 2017: Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2016 Results 186

Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 188

Jul 28, 2016: Thermo Fisher Scientific Reports Second Quarter 2016 Results 190

Apr 28, 2016: Thermo Fisher Scientific Reports First Quarter 2016 Results 192

Jan 28, 2016: Thermo Fisher Scientific Reports Record Fourth Quarter and Full Year 2015 Results 194

Corporate Communications 196

Mar 01, 2017: Thermo Fisher Scientific Elects New Director to Board 196

May 10, 2016: Thermo Fisher Scientific Reports Progress on Global Corporate Social Responsibility 197

Jan 27, 2016: Orbitrap Fusion Lumos Tribrid Mass Spectrometer Wins Scientists' Choice Award for Best New Drug Discovery Product of 2015 198

Legal and Regulatory 199

Jan 23, 2017: ISO 17025 Accreditation for Microbiology Manufacturing Site Offers Increased Confidence to Microbiology Testing Laboratories 199

Product News 200

Jun 29, 2017: New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections 200

Jun 05, 2017: Thermo Fisher Scientific and BIOCRATES Life Sciences Launch Industry's First Kit for Comprehensive Metabolome Analysis 201

Jun 02, 2017: Newly Redesigned Panels Align with Most Recent Published Evidence to Drive Cancer Research 202

May 24, 2017: New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost 203

May 22, 2017: Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis Technology with new Applied Biosystems SeqStudio Genetic Analyzer 204

Mar 21, 2017: New Comprehensive Carrier Screening Research Assay Features Richest Pan-Ethnic Panel for Detection of Multiple Genetic Variations in Inherited Disease 205

Mar 20, 2017: Thermo Fisher Scientific Showcases Newest Bioprocessing Technologies at INTERPHEX 206

Nov 01, 2016: Angsana provides tests for allergen sensitization specific for Asian population 207

Oct 18, 2016: Thermo Fisher Scientific Announces Next-Generation Transcriptome Profiling Assays for Fast Biomarker Discovery 208

Oct 17, 2016: Thermo Fisher Scientific Enables Preemptive Pharmacogenomic Screening Research with New PharmacoScan Solution 209

Aug 01, 2016: Thermo Fisher Scientific Expands Offering for Clinical Applications at AACC 2016 210

Aug 01, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease 211

Jul 25, 2016: Advanced Software Package Designed to Reduce Sample Analysis Time for Analytical Microscope Users 212

Jul 19, 2016: New system uses electrical conductivity to measure dry blood samples used in infant HIV screening, testing for metabolic disorders 213

Jul 07, 2016: Thermo Fisher Scientific Announces Next-Generation Sequencing Assay for Liquid Biopsy Research 214

Jun 28, 2016: Thermo Fisher Scientific Features Capabilities to Advance Future of Precision Medicine at Festival of Genomics 215

Jun 17, 2016: Thermo Fisher Scientific Workshop Session and Poster Presentation at ASM Microbe 2016 216

May 16, 2016: Thermo Fisher Scientific Receives FDA Clearance for EliA Anti-Thyroglobulin and Anti-Thyroid Peroxidase Tests for Autoimmune Thyroid Disease 217

May 12, 2016: Thermo Fisher Scientific: Second Generation Cell Imaging System Enables Higher-Quality Experiments 218

May 10, 2016: Native Mobile Capabilities Added to Thermo Scientific SampleManager LIMS 219

May 10, 2016: New Instruments and Software, iCAP RQ ICP-MS spectrometer and Qtegra Intelligent Scientific Data Solution software Designed to Improve Trace Elemental Analysis 220

May 10, 2016: New UHPLC-MS Workflows, protein analysis kits, columns and software Designed for Biopharmaceutical Characterization 221

Apr 26, 2016: Thermo Fisher Scientific Strengthens Bioprocessing Capabilities with New Products at INTERPHEX 2016 222

Mar 16, 2016: Thermo Fisher Scientific Launches New Forensic Enterprise Software 223

Mar 07, 2016: New Easy-to-Use Microscopes Bring the Benefits of Raman Spectroscopy to More Analytical Labs 224

Mar 07, 2016: New FT-NIR Spectrometer is Lightweight, Compact and Cost-Effective 225

Mar 07, 2016: New High-Pressure Ion Chromatography System Delivers New Levels of Simplicity and Flexibility 226

Mar 07, 2016: New Instruments and Software Designed to Improve Trace Elemental Analysis 227

Mar 07, 2016: New UHPLC Columns Offer Users Expanded Application Flexibility 228

Mar 07, 2016: New UHPLC-MS Workflows Designed for Biopharmaceutical Characterization 229

Mar 07, 2016: New UV-Vis Spectrophotometers Make it Easier to Determine Sample Quality and Suitability 230

Mar 07, 2016: New Visible-Range Spectrophotometer Enables Colorimetric Analysis in Education and QA/QC 231

Mar 07, 2016: Thermo Fisher Scientific Continues to Expand Leading Analytical Instruments Offering for Customers in Applied Markets 232

Mar 01, 2016: Accurately Detect Volatile Organic Compounds in Manufactured Products 233

Mar 01, 2016: Thermo Fisher Scientific Announces Expanded FDA Clearance for its B.R. A. H. M. S PCT Sepsis Biomarker 234

Feb 23, 2016: Thermo Fisher Scientific Exhibits ClinQuan MD Software for In Vitro Diagnostic Use at MSACL 2016 235

Feb 23, 2016: Thermo Fisher Scientific Exhibits Endura MD Mass Spectrometer for In Vitro Diagnostic Use at MSACL 2016 236

Feb 23, 2016: Thermo Fisher Scientific Exhibits Prelude MD HPLC for In Vitro Diagnostic Use at MSACL 2016 237

Feb 22, 2016: Thermo Fisher Scientific Offers EUROIMMUN Anti-Zika Virus Test Kits 238

Feb 18, 2016: Children's Hospital Los Angeles Announces Development of Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer Research 239

Feb 04, 2016: New Benchtop Centrifuge Incorporates Hybrid Rotor for Application Flexibility 240

Jan 28, 2016: Thermo Fisher Scientific brings in Europe a new B.R. A. H. M. S PCT test for the Samsung IB10 Point-of-care platform on the market 241

Jan 27, 2016: New Nano LC System with ProFlow Technology Offers Advanced Low-flow Performance 242

Product Approvals 243

Mar 01, 2016: Thermo Fisher Scientific Announces Expanded FDA Clearance for its B.R. A. H. M. S PCT Sepsis Biomarker 243

Other Significant Developments 244

Jun 12, 2017: Allergen Sensitization Testing Breakthrough Marks 50th Anniversary 244

Oct 17, 2016: Thermo Fisher Scientific Joins Cancer Moonshot Effort 245

Jul 18, 2016: Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP Allergy Testing Products 246

Jun 01, 2016: Ion Torrent Developers Alliance Program Designed to Speed Targeted NGS Assay Development 247

Feb 17, 2016: Next-Generation Large Molecule Affinity Purification Solution Improves Biotherapeutic, Disease Biomarker and Sports Anti-Doping Bioanalysis 248

Appendix 249

Methodology 249

About GlobalData 249

Contact Us 249

Disclaimer 249

List of Figures

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 13

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 15

Thermo Fisher Scientific Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 16

List of Tables

Thermo Fisher Scientific Inc, Medical Equipment, Key Facts, 2016 1

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 13

Thermo Fisher Scientific Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 14

Thermo Fisher Scientific Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 15

Thermo Fisher Scientific Inc, Deals By Market, 2011 to YTD 2017 16

Thermo Fisher Scientific Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 17

Visualization Sciences Completes Acquisition Of Amira 3D Visualization And Analysis Software From Visage Imaging For US$15 Million 26

Thermo Fisher Scientific Acquires Rights To Pre-eclampsia Biomarker From Nephromics 27

KonTEM Raises Funds Through Venture Financing 27

GTCR Completes Acquisition of Cole-Parmer from Thermo Fisher for USD480 Million 28

One Lambda Enters into Licensing Agreement with Transcriptome Sciences 29

Singulex Enters into Licensing agreement with Thermo Fisher Scientific 30

Thermo Fisher Scientific Enters into Licensing Agreement with Probiogen for GlymaxX Technology 31

Affymetrix Enters into Licensing Agreement with Peptide Groove 31

diaDexus Enters Into Licensing Agreement With Thermo Fisher Scientific 32

Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests 33

Thermo Fisher Scientific Extends Licensing Agreement With Roche For Procalcitonin Test 34

Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells 35

Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay 35

Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests 36

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 37

Vela Diagnostics Enters Into Licensing Agreement With Life Technologies 38

Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology 39

Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology 39

Thermo Fisher Scientific Extends Licensing Agreement With Wako Pure Chemical Industries 40

Affymetrix Enters Into Licensing Agreement With Genisphere 41

Thermo Fisher Scientific Enters Into Licensing Agreement With Alere 42

Seegene Enters into Agreement with Thermo Fisher Scientific 43

Thermo Fisher Scientific Enters into Agreement with Agios Pharma 44

Thermo Fisher Scientific Enters into Agreement with Institute of Medical Genetics and Pathology at University Hospital 44

Asuragen Enters into Agreement with Thermo Fisher Scientific 45

Invivoscribe Enters into Agreement with Thermo Fisher Scientific 46

Biocartis Group Enters into Distribution Agreement with Thermo Fisher Scientific 47

Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies 47

Thermo Fisher Scientific Enters into Co-Development Agreement with HEALTH BioMed 48

Thermo Fisher Scientific Enters into Co-Development Agreement with Cytonome 49

Strata Oncology Enters into Agreement with Thermo Fisher Scientific 50

Thermo Fisher Scientific Partners with University of Birmingham 50

HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 51

Thermo Fisher Scientific Enters into Co-Development Agreement with Children's Hospital Los Angeles 52

Invivoscribe Enters into Co-Development Agreement with Thermo Fisher Scientific 53

Affymetrix Enters into Agreement with Reveal Biosciences 54

Thermo Fisher Scientific Enters into Agreement with Novartis and Pfizer 54

Agilent Technologies Enters into Agreement with Thermo Fisher Scientific 55

XRGenomics Enters into Research Agreement with Affymetrix 56

Affymetrix Enters into Distribution Agreement with Luminex 57

Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 57

Cytox Enters into Joint Development Partnership with Affymetrix 58

Atossa Genetics Enters into Distribution Agreement with Thermo Fisher 59

Thermo Fisher Scientific Enters into Distribution Agreement with Cynvenio Biosystems 60

Thermo Fisher Scientific Enters into Co-Development Agreement with Samsung Electronics 60

Ingen Expands Distribution Agreement with One Lambda 61

Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer 62

Lucigen Enters into Agreement with Thermo Fisher Scientific 63

Nuclea Biotech Enters into Co-Development Agreement with Thermo Fisher Scientific 64

Thermo Fisher Scientific Enters into Co-Development Agreement with Agricultural Research Service and Pennsylvania State University 64

Affymetrix Enters Into Integration Agreement With CollabRx 65

Copan Diagnostics Enters Into Distribution Agreement With Thermo Fisher For WASP 66

OraSure Technologies Enters Into Co-Development Agreement With Thermo Fisher 67

Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit 68

Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 69

Thermo Fisher Scientific Enters Into Co-Marketing And Distribution Agreement With Quest Diagnostics 70

Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing 71

Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform 71

Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics 72

Thermo Fisher Scientific And NLIPCC Enter Into R&D Agreement For Personalized Cancer Treatment 72

Atossa Genetics Enters Into Distribution Agreement With Fisher Healthcare For Breast Health Devices 73

Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 74

Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools 75

Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA 76

Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 77

Life Technologies And IMEGEN Enter Into Agreement To Develop DNA Test 78

Response Biomedical Enters Into Distribution Agreement With Fisher HealthCare 79

BioDesign Institute Enters Into Co-Development Agreement With Life Technologies 79

Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay 80

Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics 81

Biocept Enters into Partnership with Life Technologies 82

Thermo Fisher Enters Into Co-Development Agreement With Immundiagnostik 82

Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions 83

CollabRx Enters Into Co-Development Agreement With Life Technologies 84

Thermo Fisher Scientific Extends Co-Development Agreement With bioMerieux For Procalcitonin Testing 85

Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 86

Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development 87

Affymetrix Enters Into Co-Development Agreement With Pathgen Dx 87

Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance 88

Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies 89

One Lambda Enters Into Co-Marketing Agreement With CellTrend 90

Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 90

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 91

Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 92

Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology 93

Nanosphere Enters Into Co-Marketing Agreement With Thermo Fisher For Verigene Products 94

Iris International Enters Into Distribution Agreement With Fisher HealthCare 95

IRIS Sample Processing Enters Into Distribution Agreement With Fisher HealthCare 95

Thermo Fisher Scientific Enters Into Distribution Agreement With BellBrook Labs 96

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 97

Thermo Fisher Scientific Enters Into Distribution Agreement With Abbott For PCT Assay For Sepsis 98

Life Technologies Enters Into Joint Venture Agreement With DaAn Gene 99

InGen BioSciences Enters into Distribution Agreement with One Lambda 99

Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals 100

Sage Science Enters Into Co-Marketing Agreement With Life Technologies 101

Life Technologies Enters Into Co-Marketing Agreement With Quidel 101

Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 102

Luminex Enters Into Distribution Agreement With Life Technologies 103

Baylor Research Enters Into Co-Development Agreement With Eureka Genomics 103

Rapid Micro Biosystems Enters Into Co-Marketing Agreement With Life Technologies 104

Affymetrix Enters Into Distribution Agreement With Thermo Fisher 105

Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs 106

Life Technologies Enters Into Licensing Agreement With Novartis 106

Thermo Fisher Scientific Enter Into Licensing Agreement With Protein Metric For Proteomics Software 107

Affymetrix to Raise USD50 Million in Private Placement of Shares 108

Thermo Fisher Scientific Announces Private Placement Of Common Stock For US$500 Million 109

Thermo Fisher Completes Public Offering Of Shares For US$2.53 Billion 110

Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million 111

Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 112

Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes 114

Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028 115

Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028 117

Thermo Fisher Scientific Raises USD1 Billion in Public Offering of 3% Notes Due 2023 119

Thermo Fisher Scientific Raises USD350 Million in Public Offering of 3.65% Notes Due 2025 120

Thermo Fisher Scientific Raises USD450 Million in Public Offering of 2.150% Notes Due 2018 121

Thermo Fisher Scientific Raises USD457 Million in Public Offering of 1.5% Notes Due 2020 122

Thermo Fisher Scientific Raises USD549.4 Million in Public Offering of 2.15% Notes Due 2022 124

Thermo Fisher Scientific Raises USD801 Million in Public Offering of 2% Notes Due 2025 125

Thermo Fisher Scientific Raises USD800 Million in Public Offering of 3.3% Notes Due 2022 127

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2044 For US$400 Million 128

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2024 For US$1 Billion 130

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2019 For US$900 Million 131

Thermo Fisher Scientific Completes Public Offering Of Notes Due 2017 For US$900 Million 133

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2018 For US$500 Million 135

Thermo Fisher Scientific Completes Public Offering Of Senior Notes Due 2023 For US$800 Million 136

Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million 138

Thermo Fisher Scientific Completes Public Offering Of 2.250% Senior Notes Due 2016 For US$1,000 Million 139

Thermo Fisher Scientific Completes Public Offering Of 3.600% Senior Notes Due 2021 For US$1,100 Million 140

Thermo Fisher Scientific Announces Public Offering Of Senior Notes Due 2022 142

Thermo Fisher Scientific Completes Public Offering Of 4.500% Senior Notes Due 2021 For US$1,000 Million 143

Thermo Fisher Scientific Completes Public Offering Of 2.050% Senior Notes Due 2014 For US$300 Million 144

Thermo Fisher Scientific Completes Public Offering Of 3.200% Senior Notes Due 2016 For US$900 Million 145

Thermo Fisher Scientific Acquires Finesse Solutions 146

Thermo Fisher Scientific Acquires FEI for USD4.2 Billion 147

Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 149

Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion 149

Thermo Fisher Scientific Acquires INEL 151

Thermo Fisher Scientific Acquires Advanced Scientifics for USD300 Million 152

FEI Company Acquires KonTEM, Developer of Innovative Phase Contrast System for TEM 153

EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 153

Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion 154

FEI Company To Acquire nanoTechnology Systems 157

Life Technologies Acquires KDR Biotech, Distributor Of Reagents 158

Thermo Fisher Scientific Acquires picoSpin, Maker Of Miniature Nuclear Magnetic Resonance Spectrometer 158

Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes 159

Thermo Fisher Scientific Completes Acquisition Of One Lambda, Transplant Diagnostics Company, For US$925 Million 160

FEI Acquires Visualization Sciences, 3D Visualization Software Company, For US$55 Million 161

Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company 162

Life Technologies Acquires Navigenics 163

Affymetrix Completes Acquisition Of eBioscience For US$315 Million 164

Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience 166

FEI Company Acquires TILL Photonics For US$19.9 Million 166

Thermo Fisher Scientific Acquires Intrinsic Bioprobes 167

Thermo Fisher Completes Acquisition Of Phadia 168

Thermo Fisher Scientific Acquires TREK Diagnostic Systems 169

Thermo Fisher Scientific Acquires Sterilin 170

Thermo Fisher Scientific Completes The Acquisition Of Dionex 171

Quest Diagnostics Completes Acquisition Of Athena Diagnostics 173

Thermo Fisher Scientific Inc, Key Competitors 176

Thermo Fisher Scientific Inc, Key Employees 177

Thermo Fisher Scientific Inc, Subsidiaries 179

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Thermo Fisher Scientific Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16065
Site License
USD 500 INR 32130
Corporate User License
USD 750 INR 48195

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com